Deals & Capital Markets
BioMarin Bets $4.8 Billion on Amicus to Create Rare Disease Powerhouse
Dec 19, 2025
You're signed outSign in or to get full access.
BIOMARIN PHARMACEUTICAL (BMRN) Earnings Call Transcripts
Browse quarterly earnings call transcripts for BIOMARIN PHARMACEUTICAL.
Q3 2025
Oct 27, 2025
Q2 2025
Aug 4, 2025
Q1 2025
May 1, 2025
Q4 2024
Feb 19, 2025
Q3 2024
Oct 29, 2024
Q2 2024
Aug 5, 2024
Q2 2021
Jul 28, 2021
Q1 2021
Apr 29, 2021
Q4 2020
Feb 25, 2021